Benil@Iqraa Kidney Care
@drbenilhafeeq.bsky.social
Nephrologist , Iqraa Kidney Care, Kozhikode, Kerala, India
Reposted by Benil@Iqraa Kidney Care
Previous #NephJC discussion of felzartamab in transplant ABMR here www.nephjc.com/news/felzart... from @kajareeg.bsky.social and @madihaaziz.bsky.social
Playing It Safe: Can Felzartamab Fill the Gap in AMR Treatment? — NephJC
This week is time antibody mediated rejection treatment in kidney transplant. A new molecule targeting CD38, on the horizon, safely tested in a phase 2 trial
www.nephjc.com
June 26, 2025 at 1:58 PM
Previous #NephJC discussion of felzartamab in transplant ABMR here www.nephjc.com/news/felzart... from @kajareeg.bsky.social and @madihaaziz.bsky.social